Roivant Sciences Ltd.

NASDAQ: ROIV · Real-Time Price · USD
11.86
0.11 (0.94%)
At close: Aug 15, 2025, 2:32 PM

Roivant Sciences Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Cash & Equivalents
2.72B 6.54B 1.68B 2.06B
Short-Term Investments
2.17B 5.37M 5.01M n/a
Long-Term Investments
302.94M 247.75M 304.32M 325.83M
Other Long-Term Assets
32.86M 39.11M 49.48M 25.82M
Receivables
n/a 82.81M 37.64M 6.73M
Inventory
n/a 35.25M 2.76M n/a
Other Current Assets
113.17M 17.59M 20.44M 26.02M
Total Current Assets
5B 6.73B 1.8B 2.15B
Property-Plant & Equipment
101.08M 65.95M 92.34M 86.95M
Goodwill & Intangibles
n/a 137.84M 144.88M n/a
Total Long-Term Assets
436.88M 490.65M 591.02M 438.61M
Total Assets
5.44B 7.22B 2.39B 2.59B
Account Payables
23.69M 53.23M 37.83M 34.58M
Deferred Revenue
1.17M 4.17M 12.44M 10.15M
Short-Term Debt
n/a 12M 40.72M n/a
Other Current Liabilities
53.93M 85.94M 74.84M 83.98M
Total Current Liabilities
149.41M 266.76M 272.45M 184.37M
Long-Term Debt
n/a 430.59M 375.51M 210.03M
Other Long-Term Liabilities
10M 29.34M 80.58M 53.09M
Total Long-Term Liabilities
100.33M 507.19M 509.57M 339.33M
Total Liabilities
249.74M 773.95M 782.02M 523.7M
Total Debt
100.17M 499.75M 481.4M 283.89M
Common Stock
n/a n/a n/a n/a
Retained Earnings
116.06M 576.17M -3.77B -2.76B
Comprehensive Income
9.44M -4.08M -2.62M -946K
Shareholders Equity
4.69B 5.97B 1.16B 1.66B
Total Investments
2.47B 247.75M 304.32M 325.83M